eMurmur

eMurmur operates in the healthcare technology sector, specializing in AI-powered digital auscultation. The company provides an advanced stethoscope platform that leverages artificial intelligence to improve the accuracy of heart murmur detection. eMurmur serves healthcare providers, telehealth companies, and academic institutions, offering a solution that addresses the challenges of traditional cardiac auscultation, such as faint heart sounds and high heart rates. The business model is primarily B2B (business-to-business), partnering with hardware manufacturers and telehealth service providers to integrate their technology into existing systems. Revenue is generated through licensing agreements, partnerships, and possibly subscription models for ongoing access to their AI algorithms and platform updates. eMurmur has been collaborating with leading international academic institutions since 2016 to validate the efficacy of its technology through clinical trials. The market for eMurmur's services includes hospitals, clinics, telehealth platforms, and educational institutions focused on cardiac health.

Keywords: AI-powered, digital auscultation, heart murmur detection, telehealth, healthcare technology, stethoscope platform, clinical trials, cardiac health, B2B, licensing.